New cardiac pump clinically superior, safer for patients
(Brigham and Women's Hospital) The study of more than 1,000 patients with severe heart failure not only confirms that the HeartMate 3 , a next-generation LVAD device, markedly reduced the need for re-operations due to pump malfunctions, but also found that it lowered risk of bleeding events and strokes, compared to the HeartMate II .
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Bleeding | Cardiology | Heart | Heart Failure | Hospitals | International Medicine & Public Health | Stroke | Study | Women